Clinical trials confirmed no effect on serum IGF-1 levels, no negative effect on carbohydrate metabolism, and no anti-AOD-9604 antibodies detected in any participants
Promotes better sleep and relaxation
Therefore, the lower body weight of the model mice at the time of intervention likely resulted in a relatively smaller degree of weight reduction upon administration of semaglutide or tirzepatide compared to previous reports
GLP-1 agonists are a type of medication used to help manage type 2 diabetes and obesity
If you are experiencing persistent or concerning fatigue whilst taking Mounjaro, it is essential to discuss this with your GP or diabetes specialist nurse
Other conditions, such as gallbladder issues, diabetic retinopathy, and kidney problems, also require careful consideration